SCHEMBL1725802

SCHEMBL1725802

COC(=O)c1ccc2c(c1)nc(Nc1cc(CN)ccc1Cl)n2C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.45
KDM4E B2RXH2 1/20 0.44
EHMT2 Q96KQ7 1/20 0.43
LOXL2 Q9Y4K0 2/20 0.43
ITK Q08881 1/20 0.43
HDAC6 Q9UBN7 3/20 0.42
DRD2 P14416 2/20 0.41
TBXA2R P21731 2/20 0.41
KCNH2 Q12809 1/20 0.41
ALDH1A1 P00352 1/20 0.41
IDH1 O75874 1/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
TLR8 Q9NR97 2/20 0.40
TLR7 Q9NYK1 2/20 0.40
CNR2 P34972 1/20 0.40
P2RX7 Q99572 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3094839 0.83 PTGES (0.44) ROCK2KDM4EEHMT2DRD2TBXA2R
SCHEMBL3098320 0.82 PTGES (0.52) KDM4EHDAC6ALDH1A1NPC1MAPT
SCHEMBL1725831 0.81 PTGES (0.61) ROCK2KDM4EEHMT2KCNH2IDH1
SCHEMBL3101603 0.80 PTGES (0.48) KDM4EHDAC6KCNH2ALDH1A1LMNA
SCHEMBL16318619 0.78 HDAC6 (0.51) ROCK2KDM4EEHMT2ITKHDAC6
SCHEMBL1974190 0.77 HDAC6 (0.47) ROCK2KDM4EEHMT2ITKHDAC6
SCHEMBL19029395 0.73 KDM4E (0.56) KDM4EEHMT2HDAC6DRD2TBXA2R
SCHEMBL1965112 0.72 HDAC6 (0.49) KDM4EEHMT2HDAC6NPC1LMNA
SCHEMBL30897550 0.71 KDM4E (0.56) ROCK2KDM4EEHMT2ITKHDAC6
SCHEMBL11947887 0.71 KDM4E (0.56) ROCK2KDM4EEHMT2ITKHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921405-B2 Compounds OREXO AB (SE) 2014-12-30 US disclosed
EP-2403852-B1 2-AMINOBENZIMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM INT (DE) 2014-10-29 EP disclosed
US-20130303571-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-11-14 US disclosed
US-20120196897-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-08-02 US disclosed
EP-2403852-A1 3H-IMIDAZO [4, 5 -C]PYRIDINE- 6 -CARBOXAMIDES AS ANTI- INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2012-01-11 EP disclosed
US-20100256188-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-07 US disclosed
WO-2010100249-A1 3H-IMIDAZO [4, 5 -C] PYRIDINE- 6 -CARBOXAMIDES AS ANTI- INFLAMMATORY AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196897-A1 NEW COMPOUNDS MTX1, LTB4R, RDX ROCK2 450/4885KDM4E 2615/4885EHMT2 3214/4885
US-20130303571-A1 NEW COMPOUNDS MTX1, LTB4R, RDX ROCK2 450/4885KDM4E 2615/4885EHMT2 3214/4885
US-20100256188-A1 NEW COMPOUNDS MTX1, LTB4R, RDX ROCK2 450/4885KDM4E 2615/4885EHMT2 3214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.